The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance

January 16, 2018 updated by: Richard Mattes, Purdue University
Assess the impact of chronic use of aspartame on glycemia, appetite and body composition.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Participants will be randomly assigned to one of three parallel arms: 0% (water), 5 mg, 15mg aspartame. Participants will have an oral glucose tolerance test at the beginning and end of a 12 week intervention. . Participants will report to the lab weekly for 12 weeks to pick up their next week's intervention products and measurements for body weight, waist circumference, blood pressure and heart rate. They will consume their intervention products daily for 12 weeks. They will record appetite sensations and collect a 24 hour urine sample at weeks 0, 4, 8, and 12.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • West Lafayette, Indiana, United States, 47907
        • Purdue Univeristy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI 18-25
  • Fasting blood sugar between 72 and 108 mg/dl via capillary finger-stick.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 0% aspartame (water)
participants will not have any aspartame, this is a control.
control group
Experimental: 5 mg aspartame
participants will receive 5 mg aspartame in a beverage.
will be given 5mg aspartame or 15 mg aspartame
Experimental: 15mg aspartame
participants will receive 5 mg aspartame in a beverage, and 10mg in capsules.
will be given 5mg aspartame or 15 mg aspartame

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 0
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 15 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 30 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 60 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 90 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 120 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 180 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 0 4 hours
sample taken at time point 240 minutes post glucola
week 0 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 0
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 15 minutes post glucola
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 30 minutes post glucola
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 60 minutes post glucola
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 90 minutes post glucola
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 120 minutes post glucola
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 180 minutes post glucola
week 12 4 hours
change oral glucose tolerance
Time Frame: week 12 4 hours
sample taken at time point 240 minutes post glucola
week 12 4 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appetite
Time Frame: every hour for 1 day at week 0
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day.
every hour for 1 day at week 0
Appetite
Time Frame: every hour for 1 day at week 4
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
every hour for 1 day at week 4
Appetite
Time Frame: every hour for 1 day at week 8
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
every hour for 1 day at week 8
Appetite
Time Frame: every hour for 1 day at week 12
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
every hour for 1 day at week 12
Body composition
Time Frame: week 0
body composition measurement Plysmography (BOD POD)
week 0
Body composition
Time Frame: week 12
body composition measurement Plysmography (BOD POD)
week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2016

Primary Completion (Actual)

May 5, 2017

Study Completion (Actual)

May 5, 2017

Study Registration Dates

First Submitted

December 19, 2016

First Submitted That Met QC Criteria

December 20, 2016

First Posted (Estimate)

December 21, 2016

Study Record Updates

Last Update Posted (Actual)

January 18, 2018

Last Update Submitted That Met QC Criteria

January 16, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 055-045

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oral Glucose Tolerance

Clinical Trials on water

Subscribe